Acutus Medical, Inc. (AFIB)
NASDAQ: AFIB · IEX Real-Time Price · USD
0.153
0.00 (-0.26%)
May 2, 2024, 3:13 PM EDT - Market open

Acutus Medical Revenue

In the year 2023, Acutus Medical had annual revenue of $7.16M with 136.36% growth. Revenue in the quarter ending December 31, 2023 was $-7.53M, a -10.01% decrease year-over-year.

Revenue (ttm)
$7.16M
Revenue Growth
+136.36%
P/S Ratio
0.63
Revenue / Employee
$31,148
Employees
230
Market Cap
4.54M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20237.16M4.13M136.36%
Dec 31, 20223.03M-14.23M-82.44%
Dec 31, 202117.26M8.80M103.96%
Dec 31, 20208.46M5.63M198.45%
Dec 31, 20192.84M670.00K30.93%
Dec 31, 20182.17M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
BIOLASE 49.16M
Leafly Holdings 42.25M
China Pharma Holdings 7.01M
Petros Pharmaceuticals 5.82M
Aditxt 645.18K
Lipella Pharmaceuticals 449.62K
Oragenics 37.65K
Revenue Rankings